Indian digital healthcare platform PharmEasy filed for an initial public offering (IPO) on Wednesday of up to 62.50 billion rupees ($842.43 million), becoming the latest start-up in the country to pursue a domestic stock listing.
API Holdings Ltd, PharmEasy's parent, may also consider a further issue of equity shares via a private placement of up to 12.50 billion rupees, the company said in its draft red herring prospectus.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.